Your browser doesn't support javascript.
loading
Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis.
Togami, Katsuhiro; Chung, Sun Sook; Madan, Vikas; Booth, Christopher A G; Kenyon, Christopher M; Cabal-Hierro, Lucia; Taylor, Justin; Kim, Sunhee S; Griffin, Gabriel K; Ghandi, Mahmoud; Li, Jia; Li, Yvonne Y; Angelot-Delettre, Fanny; Biichle, Sabeha; Seiler, Michael; Buonamici, Silvia; Lovitch, Scott B; Louissaint, Abner; Morgan, Elizabeth A; Jardin, Fabrice; Piccaluga, Pier Paolo; Weinstock, David M; Hammerman, Peter S; Yang, Henry; Konopleva, Marina; Pemmaraju, Naveen; Garnache-Ottou, Francine; Abdel-Wahab, Omar; Koeffler, H Phillip; Lane, Andrew A.
Afiliación
  • Togami K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Chung SS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Madan V; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Booth CAG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kenyon CM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Cabal-Hierro L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Taylor J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kim SS; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, Florida.
  • Griffin GK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Ghandi M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Li J; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Li YY; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Angelot-Delettre F; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Biichle S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Seiler M; Université Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Buonamici S; Université Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Lovitch SB; H3 Biomedicine, Cambridge, Massachusetts.
  • Louissaint A; H3 Biomedicine, Cambridge, Massachusetts.
  • Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Jardin F; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Piccaluga PP; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Weinstock DM; Inserm U1245, Centre Henri Becquerel, Université de Rouen, IRIB, Rouen, France.
  • Hammerman PS; Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School, Bologna, Italy.
  • Yang H; Department of Biomolecular Strategies, Genetics, Avant-Garde Therapies and Neurosciences (SBGN), Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy.
  • Konopleva M; School of Health, Department of Pathology, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
  • Pemmaraju N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Garnache-Ottou F; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Abdel-Wahab O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Koeffler HP; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Lane AA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Discov ; 12(2): 522-541, 2022 02.
Article en En | MEDLINE | ID: mdl-34615655
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleoproteínas / Células Dendríticas / Trastornos Mieloproliferativos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Discov Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleoproteínas / Células Dendríticas / Trastornos Mieloproliferativos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Discov Año: 2022 Tipo del documento: Article